An Observational Study on the Safety and Effectiveness of Rituximab in Patients With Severe Active Rheumatoid Arthritis

NCT01071798 · clinicaltrials.gov ↗

COMPLETED

Status

1653

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Rituximab

Sponsor

Hoffmann-La Roche